From: Association of a probiotic to a Helicobacter pylorieradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study
Peptic ulcer (CI 95%)
Dyspepsia (CI 95%)
Active probiotic
95.8% (87-100%)
84.0% (74-100%)
Placebo probiotic
85.7% (69-100%)
84.6% (70-99%)
Pearson Chi-Square
p = 0.23
p = 0.95